Hinge Health Q1 Adj. EPS $0.45 Beats $0.38 Estimate, Sales $182.307M Beat $172.164M Estimate

Stock Track | Hinge Health Soars 7.76% After-Hours on Strong Q1 Earnings Beat and Raised Guidance

Hinge Health Shares Rise 7% After the Bell Following Results, Outlook

Hinge Health Q1 FY26 net income rises 105% to $35.13 million; revenue increases 47% to $182.3 million

Hinge Health Inc Q1 EPS USD 0.41

Hinge Health Lifts Outlook on Strong 1Q, Sees Long Runway for Expansion

Barclays Reaffirms Their Buy Rating on Hinge Health, Inc. Class A (HNGE)

Evercore ISI Keeps Their Buy Rating on Hinge Health, Inc. Class A (HNGE)

Hinge Health Buy Rating Reiterated on Growth Momentum and Migraine Expansion, Price Target Maintained at $72

Earning Preview: Hinge Health, Inc. this quarter’s revenue is expected to increase by 0.84%, and institutional views are bullish

Hinge Health Exec Chairman Gabriel Mecklenburg disposes of shares worth $1.5 million

Hinge Health announces annual shareholder meeting

Hinge Health: Reinforcing Category Leadership and Growth Outlook Amid AI-Driven Scaling

Hinge Health Is Maintained at Outperform by Evercore ISI Group

RBC Capital Remains a Buy on Hinge Health, Inc. Class A (HNGE)

Hinge Health Exec Chairman Gabriel Mecklenburg disposes of USD 1.9 million common shares

Hinge Health updates financial calendar, schedules quarterly results and earnings call

Hinge Health reports support for over 300 public sector organizations

Hinge Health President James Pursley disposes of USD 635,000 in common shares